How to Secure Third-Party Reimbursement for Diagnostic Testing: Strategies for Every Budget

Obtaining third-party reimbursement for diagnostic tests is one of the biggest challenges faced by laboratories, especially those developing and running lab-developed tests (LDTs) under CLIA regulations. The process can be complex and resource-intensive, requiring a mix of clinical, economic, and operational strategies. While larger organizations often have the resources to invest in comprehensive studies and lobbying efforts, smaller companies must find innovative ways to achieve similar goals.

At Connexis Search Group, we’ve worked with early-stage CLIA laboratories for many years. While we’re not experts in managed care, we’ve seen firsthand the hurdles that companies face in this area. Over time, we’ve cultivated a network of consultants who specialize in managed care strategies and can offer expert guidance if needed.

This guide explores the key differences in strategies for companies with limited budgets versus those with significant resources, as well as a middle-ground approach for those looking to balance cost and effectiveness.

The Path to Reimbursement

Third-party reimbursement generally hinges on two key factors:

1. Clinical Utility: Demonstrating that the test improves patient outcomes or aids in decision-making.
2. Cost-Effectiveness: Showing that the test reduces overall healthcare costs, such as hospitalizations or ineffective treatments.

Achieving these benchmarks requires thoughtful planning and execution, regardless of budget size.

For Companies with Limited Budgets

Smaller companies face unique constraints but can still adopt impactful strategies to build a case for reimbursement:

1. Leverage Real-World Evidence (RWE)

• Start with small-scale data collection by partnering with clinics or hospitals already using your test.
• Retrospective analyses of patient outcomes can offer powerful insights without the cost of large, prospective trials.
• Use case studies and success stories to highlight the test’s value to payers and providers.

2. Focus on High-Impact Niches

• Target conditions with limited diagnostic options or high unmet needs. These are more likely to gain payer interest, even with minimal data.
• Develop a specific use case and position the test as essential for that scenario.

3. Build Physician Advocacy

• Partner with key opinion leaders (KOLs) to increase adoption and visibility.
• Educate physicians on the clinical value of the test and how to document its necessity for payer consideration.

4. Prioritize Operational Efficiency

• Ensure flawless execution on coding, billing, and compliance. Incorrect coding can lead to denied claims and wasted resources.
• Develop tools for physicians and patients to appeal denied claims, making the reimbursement process smoother.

5. Use Incremental Data Collection

• Start with smaller, cost-effective studies focused on specific endpoints. These can be expanded over time as revenue grows.
• Publish results in trade journals or present them at conferences to build credibility.

For Companies with Larger Budgets

Organizations with significant resources can pursue a more comprehensive approach to reimbursement:

1. Conduct Robust Clinical Utility Studies

• Invest in randomized controlled trials (RCTs) or large observational studies to provide gold-standard evidence for payers.
• Use these studies to address multiple payer concerns simultaneously, including clinical utility, cost-effectiveness, and population health impact.

2. Influence Payer Policies

• Hire reimbursement consultants or engage with payer policy teams to align your test with their coverage requirements.
• Work with medical societies to advocate for the inclusion of your test in clinical guidelines.

3. Pilot Programs with Payers

• Propose pilot studies with payers to demonstrate the test’s value in a controlled environment.
• Use data from these pilots to secure broader coverage agreements.

4. Build Comprehensive Stakeholder Education

• Develop educational campaigns targeting physicians, patients, and payers to create a strong demand for the test.
• Host webinars or create white papers that outline the clinical and economic value of your test.

5. Scale Globally

• Consider international markets with more favorable reimbursement policies as an initial revenue stream while pursuing U.S. payers.

The Middle Ground: A Hybrid Approach

For companies looking to balance cost and effectiveness, a hybrid strategy may be ideal:

1. Start with Real-World Data

• Begin collecting data from early adopters and use this to secure smaller, regional payer contracts.
• Partner with academic institutions or patient advocacy groups to offset study costs.

2. Engage in Targeted Advocacy

• Instead of lobbying for broad reimbursement, focus on specific payers or employer groups where the test’s value is most evident.
• Use testimonials from physicians and patients to support your case.

3. Create a Reimbursement Support Program

• Offer tools like sample appeal letters, coding guides, and patient financial assistance programs to make it easier for providers and patients to navigate coverage hurdles.

4. Incrementally Build Evidence

• Begin with smaller studies focused on cost-effectiveness or targeted patient populations. Use these results to secure interim reimbursement while preparing for larger clinical studies.
  
  

How Connexis Search Group Can Help

At Connexis Search Group, we’ve worked closely with early-stage CLIA laboratories for many years, helping them navigate critical challenges, including staffing and operational efficiency. While we’re not experts in managed care, we’ve developed relationships with experienced consultants who specialize in this area and can provide expert guidance to help you secure reimbursement for your tests.

If you’re seeking tailored advice or looking for connections to managed care specialists, we’re here to support you.